Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' HEINIG R' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 23 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Heinig, R; Zimmer, D; Yeh, S; Krol, GJ
      Development, validation and application of assays to quantify metrifonate and 2,2-dichlorovinyl dimethylphosphate in human body fluids

      JOURNAL OF CHROMATOGRAPHY B
    2. Heinig, R; Kitchin, N; Rolan, P
      Disposition of a single dose of warfarin in healthy individuals after pretreatment with metrifonate

      CLINICAL DRUG INVESTIGATION
    3. Heinig, R; Dietrich, H; Halabi, A
      Pharmacokinetics of metrifonate and its metabolite dichlorvos in healthy volunteers and in patients with renal impairment

      CLINICAL DRUG INVESTIGATION
    4. Heinig, R; Boettcher, M; Herman-Gnjidic, Z; Pierce, CH
      Effects of a magnesium aluminium hydroxide containing antacid, cimetidine or ranitidine on the pharmacokinetics of metrifonate and its metabolite DDVP

      CLINICAL DRUG INVESTIGATION
    5. Heinig, R; Sachse, R
      The effect of food and time of administration on the pharmacokinetic and pharmacodynamic profile of metrifonate

      INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
    6. Dingemanse, J; Halabi, A; Kleinbloesem, CH; Heinig, R; Blume, H
      Pharmacokinetics and pharmacodynamics of the acetylcholinesterase inhibitor metrifonate in patients with renal impairment

      THERAPEUTIC DRUG MONITORING
    7. Heinig, R; Adelmann, HG; Ahr, G
      The effect of ketoconazole on the pharmacokinetics, pharmacodynamics and safety of nisoldipine

      EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
    8. MOLLER JG; STASS H; HEINIG R; BLASCHKE G
      CAPILLARY-ELECTROPHORESIS WITH LASER-INDUCED FLUORESCENCE - A ROUTINEMETHOD TO DETERMINE MOXIFLOXACIN IN HUMAN-BODY FLUIDS IN VERY SMALL SAMPLE VOLUMES

      Journal of chromatography B. Biomedical sciences and applications
    9. HEINIG R
      CLINCIAL PHARMACOKINETICS OF NISOLDIPINE COAT-CORE (VOL 35, PG 191, 1998)

      Clinical pharmacokinetics
    10. HEINIG R
      CLINICAL PHARMACOKINETICS OF NISOLDIPINE COAT-CORE

      Clinical pharmacokinetics
    11. SCHMIDT BH; HEINIG R
      THE PHARMACOLOGICAL BASIS FOR METRIFONATES FAVORABLE TOLERABILITY IN THE TREATMENT OF ALZHEIMERS-DISEASE

      Dementia and geriatric cognitive disorders
    12. HEINIG R; AHR G; HAYAUCHI Y; KUHLMANN J
      PHARMACOKINETICS OF THE CONTROLLED-RELEASE NISOLDIPINE COAT-CORE TABLET FORMULATION

      International journal of clinical pharmacology and therapeutics
    13. SCHAEFER HG; HEINIG R; AHR G; ADELMANN H; TETZLOFF W; KUHLMANN J
      PHARMACOKINETIC-PHARMACODYNAMIC MODELING AS A TOOL TO EVALUATE THE CLINICAL RELEVANCE OF A DRUG-FOOD INTERACTION FOR A NISOLDIPINE CONTROLLED-RELEASE DOSAGE FORM

      European Journal of Clinical Pharmacology
    14. LANGAN J; RODRIGUEZMANAS L; SARELI P; HEINIG R
      NISOLDIPINE CC - CLINICAL-EXPERIENCE IN HYPERTENSION

      Cardiology
    15. WENSING G; HEINIG R; KUHLMANN J
      PHARMACODYNAMICS AND PHARMACOKINETICS OF BAY-X-7195 AEROSOL, A NEW AND SELECTIVE RECEPTOR ANTAGONIST OF CYSTEINYL-LEUKOTRIENES, IN NORMAL VOLUNTEERS

      British journal of clinical pharmacology
    16. MICHELUCCI R; CIPOLLA G; PASSARELLI D; GATTI G; OCHAN M; HEINIG R; TASSINARI CA; PERUCCA E
      REDUCED PLASMA NISOLDIPINE CONCENTRATIONS IN PHENYTOIN-TREATED PATIENTS WITH EPILEPSY

      Epilepsia
    17. HEINIG R
      DETERMINATION OF BAYX7195, A NOVEL LEUKOTRIENE D-4 ANTAGONIST, IN HUMAN PLASMA BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH POSTCOLUMN PHOTO DERIVATIZATION AND FLUORESCENCE DETECTION

      Journal of chromatography B. Biomedical applications
    18. HEINIG R; SCHAEFER HG; WENSING G; KUHLMANN J
      PHARMACOKINETICS, SAFETY AND TOLERABILITY OF THE ORALLY-ADMINISTERED RECEPTOR ANTAGONIST OF CYSTEINYL-LEUKOTRIENES BAY-X-7195 IN SINGLE-DOSE ESCALATION STUDIES

      International journal of clinical pharmacology and therapeutics
    19. HEINIG R; MUSCHALEK V; AHR G
      DETERMINATION OF THE ENANTIOMERS OF NISOLDIPINE IN HUMAN PLASMA USINGHIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY ON A CHIRAL STATIONARY-PHASE AND GAS-CHROMATOGRAPHY WITH MASS-SELECTIVE DETECTION

      Journal of chromatography B. Biomedical applications
    20. WENSING G; HEINIG R; PRIESNITZ M; KUHLMANN J
      EFFECT OF BAY-X-7195, AN ORAL RECEPTOR ANTAGONIST OF CYSTEINYL-LEUKOTRIENES, ON LEUKOTRIENE-D-4 INDUCED BRONCHOCONSTRICTION IN NORMAL VOLUNTEERS

      European Journal of Clinical Pharmacology
    21. WENSING G; HEINIG R; PRIESNITZ M; KUHLMANN J
      EFFECT OF BAY-X-7195, AN ORAL RECEPTOR ANTAGONIST OF CYSTEINYL-LEUKOTRIENES, ON LEUKOTRIENE-D-4 INDUCED BRONCHOCONSTRICTION IN NORMAL VOLUNTEERS

      European Journal of Clinical Pharmacology
    22. WENSING G; HEINIG R; KUHLMANN J
      EFFECT OF THE LEUKOTRIENE D-4 (LTD(4))-RECEPTOR ANTAGONIST BAY X 7195ON LTD(4)-INDUCED BRONCHOCONSTRICTION IN NORMAL SUBJECTS

      Clinical pharmacology and therapeutics
    23. RABEL SR; STOBAUGH JF; HEINIG R; BOSTICK JM
      IMPROVEMENTS IN DETECTION SENSITIVITY FOR THE DETERMINATION OF IVERMECTIN IN PLASMA USING CHROMATOGRAPHIC TECHNIQUES AND LASER-INDUCED FLUORESCENCE DETECTION WITH AUTOMATED DERIVATIZATION

      Journal of chromatography. Biomedical applications


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 20/10/20 alle ore 14:59:57